Management of cancer pain: ESMO Clinical Recommendations

Annals of Oncology

Volumn 18, Issue SUPPL. 2, 2007, Pages

  Jost, L ^a,b  

^a Kantonspital Bruderholz ^*  (Switzerland)

^b ESMO HEAD OFFICE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANTIEMETIC AGENT; BUPRENORPHINE; CHLORPROMAZINE; CLOMIPRAMINE; DICLOFENAC; DIHYDROCODEINE; FENTANYL; FLUOXETINE; HALOPERIDOL; HYDROMORPHONE; IBUPROFEN; KETOPROFEN; LAXATIVE; MEFENAMIC ACID; METHADONE; MORPHINE; MORPHINE SULFATE; NALOXONE; NAPROXEN; NEUROLEPTIC AGENT; NICOMORPHINE; NORTRIPTYLINE; OPIATE; OXYCODONE; PARACETAMOL; PSYCHOSTIMULANT AGENT; TRAMADOL; UNINDEXED DRUG;

ARTICLE; CANCER INCIDENCE; CANCER PAIN; COGNITIVE DEFECT; CONFUSION; CONSTIPATION; DROWSINESS; DRUG DOSE TITRATION; DRUG HYPERSENSITIVITY; DRUG OVERDOSE; GASTROINTESTINAL DISEASE; HALLUCINATION; HUMAN; KIDNEY DISEASE; KIDNEY DYSFUNCTION; LIVER DISEASE; MYOCLONUS; NAUSEA; NERVE BLOCK; NEUROSURGERY; PAIN ASSESSMENT; PRIORITY JOURNAL; RATING SCALE; SELF REPORT; VISUAL ANALOG SCALE; VOMITING;

ANALGESICS, OPIOID; DRUG THERAPY, COMBINATION; HUMANS; NEOPLASMS; PAIN; PAIN MEASUREMENT; SEVERITY OF ILLNESS INDEX;

EID: 44949158798     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm053     Document Type: Article

References (11)

1. Caraceni A, Cherny N, Fainsinger R et al. Pain measurement tools and methods in clinical research in palliative care: Recommendations of an expert working group of the European Association of Palliative Care. J Pain Symptom Manage 2002; 23 (3): 239-255.
2. Mercadante S, Radbruch L, Caraceni A et al. Episodic (breakthrough) pain. Consensus conference of an expert working group of the European Association for Palliative Care. Cancer 2002; 94: 832-839.
3. Fallon M, Hanks G, Cherny N. Principles of control of cancer pain. BMJ 2006; 332: 1022-1024.
4. Cherny NI. How to deal with difficult pain problems. Ann Oncol 2005; 16 (Suppl 2): Ii79-ii87.
5. Wool MS, Mor V. A mutlidimentional model for understanding cancer pain. Cancer Invest 2005; 23: 727-734.
6. Quigley C. The role of opioids in cancer pain. BMJ 2005; 331: 825-829.
7. Cherny NI. The pharmacologic management of cancer pain. Oncology 2004; 18: 1499-1515; discussion 1516, 1520-1521, 1522, 1524.
8. Luger NM, Mach DB, Sevcik MA, Mantyh PW. Bone cancer pain: From model to mechanism to therapy. J Pain Symptom Manage 2005; 29 (5 Suppl): 32S-46S.
9. Cherny N, Ripamonti C, Pereira J et al. Strategies to manage the adverse effects of oral morphine. An evidence-based report. J Clin Oncol 2001; 19: 2542-2554.
10. Hanks GW, De Conno F, Ripamonti C et al. Morphine and alternative opioids in cancer pain: Clinical recommendations. Expert working group of the research network of the European Association for Palliative Care. Br J Cancer 2001; 84: 587-593.
11. Portenoy RK, Conn M. Cancer pain syndromes. In Bruera E, Portenoy RK (eds): Cancer Pain: Assessment and Management. Cambridge, UK: Cambridge University Press 2003; 89-110.